Special considerations in low-tension glaucoma

Canadian Journal of Ophthalmology

Volumn 42, Issue 3, 2007, Pages 414-417

  Krupin, Theodore ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b University Eye Specialists   (United States)

Author keywords

Low pressure glaucoma; Neuroprotection; Randomized clinical trial

Indexed keywords

BRAIN FUNCTION; CONFERENCE PAPER; DISEASE COURSE; HUMAN; INTRAOCULAR HEMORRHAGE; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; NEUROPROTECTION; OPTIC DISK; PHYSICIAN; VISUAL FIELD DEFECT;

EID: 34250669130     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I07-043     Document Type: Conference Paper

References (30)

1. Ritch R, Shields MB, Krupin T. Preface. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. 2nd ed. St Louis, Mo: Mosby-Year Book, Inc; 1996:xvii-xviii.
2. Kerrigan-Baumrind L.A., Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci 2000;41:741-8.
3. Yücel YH, Zhang Q, Weinreb RN, Kaufman PL, Gupta N. Effects of retinal ganglion cell loss on magno-, parvo-, and koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res 2003;22:465-81.
4. Werner EB. Normal-tension glaucoma. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. 2nd ed. St. Louis, Mo: Mosby-Year Book, Inc; 1996:769-97.
5. Kass MA. Normal-pressure glaucoma (comment). Am J Ophthalmol 1998;125:212-4.
6. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-5.
7. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992;99:1499-504.
8. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-79.
9. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
10. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS). 7: the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-40.
11. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943-53.
12. Collaborative Normal-tension Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-97.
13. Collaborative Normal-tension Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998;126:498-505.
14. Tezel G, Siegmund KD, Trinkaus K, Wax MB, Kass MA, Kolker AE. Clinical factors associated with progression of glaucomatous optic disc damage in treated patients. Arch Ophthalmol 2001;119:813-8.
15. Yoles E, Wheeler LA, Schwartz M. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci 1999;40:65-73.
16. WoldeMussie E, Ruiz G, Wijono M, Wheeler LA. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci 2001;42:2849-55.
17. Krupin T, Liebmann JM, Greenfield DS, et al. The Low-pressure Glaucoma Treatment Study (LoGTS): study design and baseline characteristics of enrolled patients. Ophthalmology 2005;112:376-85.
18. Noureddin BN, Poinoosawmy D, Fietzke FW, Hitchings RA. Regression analysis of visual field progression in low tension glaucoma. Br J Ophthalmol 1991;75:493-5.
19. Chumbley LC, Brubaker RF. Low-tension glaucoma. Am J Ophthalmol 1976;81:761-7.
20. Goldberg I, Hollows FC, Kass MA, Becker B. Systemic factors in patients with low-tension glaucoma. Br J Ophthalmol 1981;65:56-62.
21. Drance SM, Sweeney VP, Morgan RW, Feldman F. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol 1973;89:457-65.
22. Geijssen HC. Studies on normal-pressure glaucoma. Amstelveen, Netherlands: Kugler; 1991.
23. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma. A case control study. Invest Ophthalmol Vis Sci 1985;26:1105-8.
24. Klein BE, Klein R, Meuer SM, Goetz LA. Migraine headache and its association with open-angle glaucoma: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1993;34:3024-7.
25. Drance SM, Douglas GR, Wijsman K, Schulzer M, Britton RJ. Response of blood flow to warm and cold in normal and low-tension glaucoma patients. Am J Ophthalmol 1988;105:35-9.
26. Poinoosawmy D, Fontana L, Wu JX, Bunce CV, Hitchings RA. Frequency of asymmetric visual field defects in normal-tension and high-tension glaucoma. Ophthalmology 1998;105:988-91.
27. Shah S, Chatterjee A, Mathai M, et al. Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology 1999;106:2154-60.
28. Weinreb RN, Levin LA. Is neuroprotection a viable therapy for glaucoma? Arch Ophthalmol 1999;117:1540-4.
29. Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci U S A 1994;91:1632-6.
30. Muir KW, Teal PA. Why have neuroprotectants failed? Lessons learned from stroke trials. J Neurol 2005;252:1011-20.